Literature DB >> 27315220

Glucagon-like peptide-1 drives energy metabolism on the synaptic highway.

Ji Liu1,2, Zhiping P Pang1,2.   

Abstract

Glucagon-like peptide-1 (GLP-1), a gut-brain hormone, coordinates energy balance in both peripheral organs and the central nervous system (CNS). In the pancreas, GLP-1 facilitates insulin exocytosis or suppresses glucagon exocytosis via multiple pathways such as regulating KATP /Kv channels, N-type Ca2+ channels, and the readily releasable pool. In the CNS, GLP-1 signaling regulates neuronal excitability in various brain regions, including neurons in the hippocampus, hypothalamus, and mesolimbic systems. GLP-1 modulation on synaptic transmission includes both pre- and postsynaptic pathways that are either excitatory or inhibitory. Synaptic transmission conveys information flow in the brain and governs brain-mediated behaviors. The study of GLP-1 control of energy metabolism at a synaptic level may shed light on the role of GLP-1 function in the brain. Various challenges remain including defining the mechanism of GLP-1 release in the brain.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  GPCR; diabetes; energy metabolism; glucagon-like peptide-1; synaptic transmission

Mesh:

Substances:

Year:  2016        PMID: 27315220     DOI: 10.1111/febs.13785

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  6 in total

Review 1.  The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.

Authors:  Mette Kruse Klausen; Morgane Thomsen; Gitta Wortwein; Anders Fink-Jensen
Journal:  Br J Pharmacol       Date:  2022-02       Impact factor: 9.473

Review 2.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

3.  Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-like Peptide-1 in the Paraventricular Hypothalamus.

Authors:  Ji Liu; Kristie Conde; Peng Zhang; Varoth Lilascharoen; Zihui Xu; Byung Kook Lim; Randy J Seeley; J Julius Zhu; Michael M Scott; Zhiping P Pang
Journal:  Neuron       Date:  2017-10-19       Impact factor: 17.173

4.  Resistance Exercise Training Attenuates the Loss of Endogenous GLP-1 Receptor in the Hypothalamus of Type 2 Diabetic Rats.

Authors:  Se Hwan Park; Jin Hwan Yoon; Dae Yun Seo; Tae Nyun Kim; Jeong Rim Ko; Jin Han
Journal:  Int J Environ Res Public Health       Date:  2019-03-07       Impact factor: 3.390

5.  Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.

Authors:  Annika Billefeld Bornebusch; Anders Fink-Jensen; Gitta Wörtwein; Randy J Seeley; Morgane Thomsen
Journal:  eNeuro       Date:  2019-04-24

6.  Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation.

Authors:  Feng Jing; Qian Zou; Yangyang Wang; Zhiyou Cai; Yong Tang
Journal:  J Headache Pain       Date:  2021-07-29       Impact factor: 7.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.